Quality of life in patients with NET undergoing SSA treatment

#3408

Introduction: Neuroendocrine tumors of the gastrointestinal tract are rare tumors representing a heterogeneous group of tumors. Somatostatin analogues are commonly used in the treatment of gastroenteropancreatic neuroendocrine tumors.

Aim(s): The aim of the study was to determine the quality of life in patients with SSA treatment.

Materials and methods: The set consisted of patients undergoing treatment with somatostatin analogues in an outpatient form. We evaluated data about disease duration, SSA treatment, and type of SSA preparation. Quality of life was evaluated by questionnaire EuroQol EQ–5D–5L and Karnofsky preformance status.

Conference:

Presenting Author: Nosakova L

Authors: Nosakova L, Uhrík P, Pindura M, Kyčina R, Miklušica J,

Keywords: neuroendocrine tumor, somatostatin analogues, quality of life,